Patents by Inventor Robert Sessions

Robert Sessions has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070059251
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Application
    Filed: September 28, 2006
    Publication date: March 15, 2007
    Applicant: Ferris Pharmaceuticals, Inc.
    Inventors: Robert Sessions, Roger Sessions, Alan Kahn
  • Publication number: 20070025925
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic swelling and/or neurogenic inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic swelling and/or neurogenic inflammation.
    Type: Application
    Filed: September 29, 2006
    Publication date: February 1, 2007
    Applicant: Ferris Pharmaceuticals, Inc.
    Inventors: Robert Sessions, Alan Kahn
  • Publication number: 20070025922
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of neurogenic pain in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of neurogenic pain.
    Type: Application
    Filed: September 29, 2006
    Publication date: February 1, 2007
    Applicant: Ferris Pharmaceuticals, Inc.
    Inventors: Robert Sessions, Alan Kahn
  • Publication number: 20070025924
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of swelling and/or inflammation in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of swelling and/or inflammation.
    Type: Application
    Filed: September 29, 2006
    Publication date: February 1, 2007
    Applicant: Ferris Pharmaceuticals, Inc.
    Inventors: Robert Sessions, Alan Kahn
  • Publication number: 20060210529
    Abstract: The present invention provides a method of attenuating the formation or reducing the severity of a neurogenic bruise in the tissue of a patient via applying a composition comprising a hydrophilic foam substrate and a polymeric hydrophilic agent to a portion of the surface of the skin in an amount and at a location sufficient to attenuate formation of or reduce the severity of bruising.
    Type: Application
    Filed: May 25, 2006
    Publication date: September 21, 2006
    Applicant: Ferris Pharmaceuticals Inc.
    Inventors: Robert Sessions, Alan Kahn
  • Publication number: 20050107731
    Abstract: The invention provides a wound dressing comprising a body and a polymeric film adhered to at least a portion of the body. The body comprises a flexible, porous polyurethane-based foam and a liquid absorbing component. The invention further provides a wound dressing comprising a first body, a second body, and at least one polymeric film disposed between the first and second bodies. The invention additionally provides methods for treating an injury to a patient's nasal passages utilizing a wound dressing according to the invention.
    Type: Application
    Filed: September 22, 2004
    Publication date: May 19, 2005
    Applicant: Ferris Pharmaceuticals Inc.
    Inventor: Robert Sessions